Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023

[ASFN Admin]

WAYNE, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced it will report financial results for the first quarter 2023 on Monday, May 8, 2023, before the opening of the U.S. financial markets. Management will conduct a conference call at 8:00 AM ET on the same day to discuss Aclaris’ financial results and to provide a corporate upda

Continue reading...